Eton Pharmaceuticals

ETONNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.632 B

$57.09 +3.22%

Close of 22 Sept 2026

Revenue

$80.0M

#2582 by revenue

Earnings

-$4.60M

Loss-making

Shares outstanding

28,583,135

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#122Tyra BiosciencesTYRA$1.76B
#123Kailera TherapeuticsKLRA$1.66B
#124Eton PharmaceuticalsETON$1.63B
#125Syndax PharmaceuticalsSNDX$1.62B
#126AnaptysbioANAB$1.60B

What if Eton Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,057,756

Per share 18,528× higher

Bitcoin $1.74T

$60,932.96

Per share 1,067× higher

Nvidia $5.52T

$192,972.78

Per share 3,380× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Eton Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.